Brookfield Corp’s Definitive Healthcare DH Stock Holding History

Brookfield Corp’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-75,000	Closed	-$3.21M	–	662
2021 Q3	$3.21M	Buy	+75,000	New	+$3.33M	0.01%	281

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

SEM

Spectrum Equity Management San Francisco, California $39.1M AUM 63.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Brookfield Corp's DH Position: Q4 2021 in Review

Brookfield Corp sold out of Definitive Healthcare (DH) in Q4 2021, closing a stake of 75,000 shares — an estimated $3.21M sold.

Brookfield Corp first reported a position in DH in Q3 2021 and held it in 1 quarter. The position peaked at $3.21M in Q3 2021. 92 funds tracked by Wall St. Rank hold DH as of Q4 2021.

Brookfield Corp reported no remaining Definitive Healthcare position as of Q4 2021 after selling out during the quarter.
Brookfield Corp sold 75,000 Definitive Healthcare shares in Q4 2021, an estimated $3.21M.
Brookfield Corp first reported a position in Definitive Healthcare in Q3 2021 and held it in 1 quarter.
Brookfield Corp's Definitive Healthcare position peaked at $3.21M in Q3 2021.
92 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2021.

Based on Brookfield Corp's 13F filing for Q4 2021, filed 14 Feb 2022.